190 related articles for article (PubMed ID: 37422281)
1. Quantitative Systems Pharmacology for Rare Disease Drug Development.
Bai JP; Wang J; Zhang Y; Wang L; Jiang X
J Pharm Sci; 2023 Sep; 112(9):2313-2320. PubMed ID: 37422281
[TBL] [Abstract][Full Text] [Related]
2. Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development: A Workshop Report.
Bai JPF; Stinchcomb AL; Wang J; Earp J; Stern S; Schuck RN
Clin Pharmacol Ther; 2024 Feb; 115(2):201-205. PubMed ID: 37984065
[TBL] [Abstract][Full Text] [Related]
3. Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration.
Bai JPF; Earp JC; Florian J; Madabushi R; Strauss DG; Wang Y; Zhu H
CPT Pharmacometrics Syst Pharmacol; 2021 Dec; 10(12):1479-1484. PubMed ID: 34734497
[TBL] [Abstract][Full Text] [Related]
4. Applications of Quantitative System Pharmacology Modeling to Model-Informed Drug Development.
Zhu AZX; Rogge M
Methods Mol Biol; 2022; 2486():71-86. PubMed ID: 35437719
[TBL] [Abstract][Full Text] [Related]
5. FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective.
Bai JPF; Schmidt BJ; Gadkar KG; Damian V; Earp JC; Friedrich C; van der Graaf PH; Madabushi R; Musante CJ; Naik K; Rogge M; Zhu H
AAPS J; 2021 Apr; 23(3):60. PubMed ID: 33931790
[TBL] [Abstract][Full Text] [Related]
6. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
Cheng L; Qiu Y; Schmidt BJ; Wei GW
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.
Geerts H; Wikswo J; van der Graaf PH; Bai JPF; Gaiteri C; Bennett D; Swalley SE; Schuck E; Kaddurah-Daouk R; Tsaioun K; Pelleymounter M
CPT Pharmacometrics Syst Pharmacol; 2020 Jan; 9(1):5-20. PubMed ID: 31674729
[TBL] [Abstract][Full Text] [Related]
8. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
Aghamiri SS; Amin R; Helikar T
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
[TBL] [Abstract][Full Text] [Related]
9. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
10. From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
Lemaire V; Bassen D; Reed M; Song R; Khalili S; Lien YTK; Huang L; Singh AP; Stamatelos S; Bottino D; Hua F
Clin Pharmacol Ther; 2023 May; 113(5):963-972. PubMed ID: 36282521
[TBL] [Abstract][Full Text] [Related]
11. Physiological Indirect Response Model to Omics-Powered Quantitative Systems Pharmacology Model.
Uatay A; Gall L; Irons L; Tewari SG; Zhu XS; Gibbs M; Kimko H
J Pharm Sci; 2024 Jan; 113(1):11-21. PubMed ID: 37898164
[TBL] [Abstract][Full Text] [Related]
12. The convergence of pharmacometrics and quantitative systems pharmacology in pharmaceutical research and development.
Joshi A; Ramanujan S; Jin JY
Eur J Pharm Sci; 2023 Mar; 182():106380. PubMed ID: 36638898
[TBL] [Abstract][Full Text] [Related]
13. [An introduction to QSP modeling for pharmacologists].
Sayama H; Nagasaka Y; Tabata K
Nihon Yakurigaku Zasshi; 2019; 154(3):143-150. PubMed ID: 31527365
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Systems Pharmacology and Machine Learning: A Match Made in Heaven or Hell?
Tindall MJ; Cucurull-Sanchez L; Mistry H; Yates JWT
J Pharmacol Exp Ther; 2023 Oct; 387(1):92-99. PubMed ID: 37652709
[TBL] [Abstract][Full Text] [Related]
15. [Estimation of mechanism-of-action of pharmaceutical compounds based on quantitative systems pharmacology].
Saito R
Nihon Yakurigaku Zasshi; 2019; 153(3):124-128. PubMed ID: 30867381
[TBL] [Abstract][Full Text] [Related]
16. The promises of quantitative systems pharmacology modelling for drug development.
Knight-Schrijver VR; Chelliah V; Cucurull-Sanchez L; Le Novère N
Comput Struct Biotechnol J; 2016; 14():363-370. PubMed ID: 27761201
[TBL] [Abstract][Full Text] [Related]
17. Virtual Populations for Quantitative Systems Pharmacology Models.
Cheng Y; Straube R; Alnaif AE; Huang L; Leil TA; Schmidt BJ
Methods Mol Biol; 2022; 2486():129-179. PubMed ID: 35437722
[TBL] [Abstract][Full Text] [Related]
18. Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development.
Azer K; Barrett JS
CPT Pharmacometrics Syst Pharmacol; 2022 Jul; 11(7):797-804. PubMed ID: 35411657
[TBL] [Abstract][Full Text] [Related]
19. Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities.
Abuasal B; Ahmed MA; Patel P; Albusaysi S; Sabarinath S; Uppoor R; Mehta M
Clin Pharmacol Ther; 2022 Apr; 111(4):786-798. PubMed ID: 34860361
[TBL] [Abstract][Full Text] [Related]
20. Overview of Clinical Pharmacology Packages of New Drug Applications Approved for the Treatment of Rare Diseases.
Qosa H; Hassan HE; Younis IR
J Clin Pharmacol; 2022 Dec; 62 Suppl 2():S72-S78. PubMed ID: 36461747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
